Journal article
The treatment of patients with low tumour burden and/or slow growing disease.
- Abstract:
-
In the evaluation of the wide range of novel therapeutics which have been developed, investigators do not have to be tied to the current paradigm of demonstrating additive efficacy to first line combination therapy. The addition of new agents to FOLFOX regimens has proved a high hurdle at which many promising agents have fallen. In those patients with slow growing disease or low tumour burden both the use of novel agents in a window of opportunity trial before conventional chemotherapy or in ...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- European journal of cancer (Oxford, England : 1990)
- Volume:
- 47 Suppl 3
- Issue:
- SUPPL. 3
- Pages:
- S67-S75
- Publication date:
- 2011-09-01
- DOI:
- EISSN:
-
1879-0852
- ISSN:
-
0959-8049
- Source identifiers:
-
186126
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:186126
- UUID:
-
uuid:aa1323d8-cad5-412e-a351-cbd4d0a3ecaa
- Local pid:
- pubs:186126
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2011
If you are the owner of this record, you can report an update to it here: Report update to this record